Marinus Pharmaceuticals Competitors and Similar CompaniesClear all
Marinus Pharmaceuticals's competitors and similar companies include CureVac, CSL Behring and Cadila Pharmaceuticals.
 Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. | ||||
Founding Date | Founding Date 2003 | Founding Date 2000 | Founding Date 1904 | Founding Date 1951 |
Type | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations Radnor, US HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | |
Employees | Employees 402% decrease | Employees 82517% decrease | Employees 7,5692% decrease | Employees 8,5201% increase |
Valuation ($) | Valuation ($) 16 m | Valuation ($) 648.3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $31m (FY, 2023) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) N/A |
Gross profit | Gross profit N/A | Gross profit €534.4m (FY, 2024) | Gross profit $4.5b (FY, 2020) | Gross profit N/A |
Net income | Net income ($141.4m) (FY, 2023) | Net income €162.2m (FY, 2024) | Net income N/A | Net income N/A |
Operating ⚠ | ||||
Patent Applications | Patent Applications N/A | Patent Applications 500 (Mar, 2020) | Patent Applications 3 (Dec, 2020) | Patent Applications N/A |
Funding | ||||
Total funding raised | Total funding raised $ 81.8m | Total funding raised $ 1.1b | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View companyCadila Pharmaceuticals
HQ
Bavla, IN
Employees
8,520↑ 1% increase
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View company